Alkermes Inc. plc (ALKS)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.27 (+0.87%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Alkermes Inc. plc (ALKS)
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Key Insights

Critical company metrics and information
  • Share Price

    $31.46
  • Market Cap

    $5.09 Billion
  • Total Outstanding Shares

    161.80 Million Shares
  • Total Employees

    2,100
  • Dividend

    No dividend
  • IPO Date

    July 16, 1991
  • SIC Description

    Pharmaceutical Preparations
  • Homepage

    https://www.alkermes.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Investing Activities, Continuing$-118.42 Million
Net Cash Flow From Financing Activities$-488.97 Million
Net Cash Flow From Investing Activities$-118.42 Million
Net Cash Flow From Financing Activities, Continuing$-488.97 Million
Net Cash Flow From Operating Activities, Continuing$355.96 Million
Net Cash Flow, Continuing$-251.42 Million
Net Cash Flow$-251.42 Million
Net Cash Flow From Operating Activities$355.96 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Revenues$1.51 Billion
Income/Loss From Discontinued Operations Net Of Tax$-53.61 Million
Diluted Earnings Per Share$1.98
Preferred Stock Dividends And Other Adjustments$0.00
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Net Income/Loss$333.35 Million
Other Operating Expenses$10.08 Million
Selling, General, and Administrative Expenses$668.03 Million
Operating Income/Loss$312.58 Million
Cost Of Revenue$253.34 Million
Benefits Costs and Expenses$1.17 Billion
Net Income/Loss Available To Common Stockholders, Basic$333.35 Million
Nonoperating Income/Loss$19.60 Million
Basic Average Shares$331.75 Million
Costs And Expenses$1.19 Billion
Income/Loss From Continuing Operations Before Tax$332.18 Million
Net Income/Loss Attributable To Parent$333.35 Million
Operating Expenses$939.20 Million
Income/Loss From Continuing Operations After Tax$386.95 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Income Tax Expense/Benefit$-54.78 Million
Basic Earnings Per Share$2.01
Research and Development$261.08 Million
Gross Profit$1.25 Billion
Diluted Average Shares$337.73 Million
Income Tax Expense/Benefit, Deferred$-20.20 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Noncurrent Assets$591.11 Million
Equity$1.29 Billion
Current Liabilities$453.70 Million
Equity Attributable To Parent$1.29 Billion
Current Assets$1.56 Billion
Other Current Assets$1.01 Billion
Noncurrent Liabilities$409.48 Million
Inventory$191.09 Million
Liabilities$863.18 Million
Assets$2.16 Billion
Fixed Assets$225.42 Million
Equity Attributable To Noncontrolling Interest$0.00
Wages$55.90 Million
Accounts Receivable$367.21 Million
Liabilities And Equity$2.16 Billion
Other Non-current Assets$365.69 Million
Accounts Payable$37.04 Million
Other Current Liabilities$360.76 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Related Companies

View additional S&P 500 companies similar to Alkermes Inc. plc (ALKS)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.